These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
265 related items for PubMed ID: 30041139
1. Synthesis and biological evaluation of benzo[b]furo[3,4-e][1,4]diazepin-1-one derivatives as anti-cancer agents. Malayeri SO, Tayarani-Najaran Z, Behbahani FS, Rashidi R, Delpazir S, Ghodsi R. Bioorg Chem; 2018 Oct; 80():631-638. PubMed ID: 30041139 [Abstract] [Full Text] [Related]
2. Synthesis and biological evaluation of novel benzo[c]acridine-diones as potential anticancer agents and tubulin polymerization inhibitors. Behbahani FS, Tabeshpour J, Mirzaei S, Golmakaniyoon S, Tayarani-Najaran Z, Ghasemi A, Ghodsi R. Arch Pharm (Weinheim); 2019 Jun; 352(6):e1800307. PubMed ID: 31012156 [Abstract] [Full Text] [Related]
3. Design, synthesis, biological evaluation, and 3D-QSAR analysis of podophyllotoxin-dioxazole combination as tubulin targeting anticancer agents. Wang ZZ, Sun WX, Wang X, Zhang YH, Qiu HY, Qi JL, Pang YJ, Lu GH, Wang XM, Yu FG, Yang YH. Chem Biol Drug Des; 2017 Aug; 90(2):236-243. PubMed ID: 28079286 [Abstract] [Full Text] [Related]
4. Synthesis and biological evaluation of podophyllotoxin congeners as tubulin polymerization inhibitors. Kamal A, Srinivasa Reddy T, Polepalli S, Shalini N, Reddy VG, Subba Rao AV, Jain N, Shankaraiah N. Bioorg Med Chem; 2014 Oct 01; 22(19):5466-75. PubMed ID: 25131956 [Abstract] [Full Text] [Related]
5. Synthesis and biological evaluation of a series of podophyllotoxins derivatives as a class of potent antitubulin agents. Liu Y, Wei D, Zhao Y, Cheng W, Lu Y, Ma Y, Li X, Han C, Wei Y, Cao H, Zhao C. Bioorg Med Chem; 2012 Nov 01; 20(21):6285-95. PubMed ID: 23022053 [Abstract] [Full Text] [Related]
6. Investigation of podophyllotoxin esters as potential anticancer agents: synthesis, biological studies and tubulin inhibition properties. Shareef MA, Duscharla D, Ramasatyaveni G, Dhoke NR, Das A, Ummanni R, Srivastava AK. Eur J Med Chem; 2015 Jan 07; 89():128-37. PubMed ID: 25462233 [Abstract] [Full Text] [Related]
7. Synthesis of a terphenyl substituted 4-aza-2,3-didehydropodophyllotoxin analogues as inhibitors of tubulin polymerization and apoptosis inducers. Kamal A, Tamboli JR, Nayak VL, Adil SF, Vishnuvardhan MV, Ramakrishna S. Bioorg Med Chem; 2014 May 01; 22(9):2714-23. PubMed ID: 24721832 [Abstract] [Full Text] [Related]
8. Synthesis of a new 4-aza-2,3-didehydropodophyllotoxin analogues as potent cytotoxic and antimitotic agents. Kamal A, Suresh P, Mallareddy A, Kumar BA, Reddy PV, Raju P, Tamboli JR, Shaik TB, Jain N, Kalivendi SV. Bioorg Med Chem; 2011 Apr 01; 19(7):2349-58. PubMed ID: 21402478 [Abstract] [Full Text] [Related]
9. Synthesis and biological evaluation of 4-aza-2,3-dihydropyridophenanthrolines as tubulin polymerization inhibitors. Kamal A, Srinivasa Reddy T, Polepalli S, Paidakula S, Srinivasulu V, Ganga Reddy V, Jain N, Shankaraiah N. Bioorg Med Chem Lett; 2014 Aug 01; 24(15):3356-60. PubMed ID: 24953821 [Abstract] [Full Text] [Related]
10. Design, synthesis, and biological evaluation of combretabenzodiazepines: a novel class of anti-tubulin agents. Galli U, Travelli C, Aprile S, Arrigoni E, Torretta S, Grosa G, Massarotti A, Sorba G, Canonico PL, Genazzani AA, Tron GC. J Med Chem; 2015 Feb 12; 58(3):1345-57. PubMed ID: 25584687 [Abstract] [Full Text] [Related]
11. Synthesis and Biological evaluation of novel 4β-[(5-substituted)-1,2,3,4-tetrazolyl] podophyllotoxins as anticancer compounds. Hyder I, Yedlapudi D, Kalivendi SV, Khazir J, Ismail T, Nalla N, Miryala S, Sampath Kumar HM. Bioorg Med Chem Lett; 2015 Jul 15; 25(14):2860-3. PubMed ID: 26022842 [Abstract] [Full Text] [Related]
12. Synthesis of d-ring modified acid hydrazide derivatives of podophyllotoxin and their anticancer studies as Tubulin inhibiting agents. Nerella S, Kankala S, Paidakula S, Gavaji B. Bioorg Chem; 2020 Jan 15; 94():103384. PubMed ID: 31776036 [Abstract] [Full Text] [Related]
13. Design, synthesis and biological evaluation of novel podophyllotoxin derivatives as tubulin-targeting anticancer agents. Guo Y, Chen B, Guo J, Jiang P, Wang J, Sun W. Pharm Biol; 2024 Dec 15; 62(1):233-249. PubMed ID: 38393642 [Abstract] [Full Text] [Related]
14. Synthesis and cytotoxicity evaluation of novel podophyllotoxin derivatives. Chengniu W, Zhonghua W, Yu Z, Chunyan N, Xiaodong Z, Li Z. Arch Pharm (Weinheim); 2011 Nov 15; 344(11):735-40. PubMed ID: 21887802 [Abstract] [Full Text] [Related]
15. Synthesis and biological evaluation of cytotoxic activity of novel podophyllotoxin derivatives incorporating piperazinyl-cinnamic amide moieties. Zhang X, Yang T, Jin X, Lin K, Dai X, Gao T, Huang G, Fan M, Ma L, Liu Z, Cao J. Bioorg Chem; 2022 Jun 15; 123():105761. PubMed ID: 35358823 [Abstract] [Full Text] [Related]
16. Novel Podophyllotoxin Derivatives as Potential Tubulin Inhibitors: Design, Synthesis, and Antiproliferative Activity Evaluation. Han HW, Lin HY, He DL, Ren Y, Sun WX, Liang L, Du MH, Li DC, Chu YC, Yang MK, Wang XM, Yang YH. Chem Biodivers; 2018 Nov 15; 15(11):e1800289. PubMed ID: 30194898 [Abstract] [Full Text] [Related]
17. Synthesis of macrocyclic bisbibenzyl derivatives and their anticancer effects as anti-tubulin agents. Jiang J, Sun B, Wang YY, Cui M, Zhang L, Cui CZ, Wang YF, Liu XG, Lou HX. Bioorg Med Chem; 2012 Apr 01; 20(7):2382-91. PubMed ID: 22365913 [Abstract] [Full Text] [Related]
18. Novel hybrids of podophyllotoxin and formononetin inhibit the growth, migration and invasion of lung cancer cells. Yang C, Xie Q, Zeng X, Tao N, Xu Y, Chen Y, Wang J, Zhang L. Bioorg Chem; 2019 Apr 01; 85():445-454. PubMed ID: 30776555 [Abstract] [Full Text] [Related]
19. Synthesis and biological evaluation of podophyllotoxin derivatives as selective antitumor agents. Wu GR, Xu B, Yang YQ, Zhang XY, Fang K, Ma T, Wang H, Xue NN, Chen M, Guo WB, Jia XH, Wang PL, Lei HM. Eur J Med Chem; 2018 Jul 15; 155():183-196. PubMed ID: 29886322 [Abstract] [Full Text] [Related]
20. Synthesis and biological evaluation of substituted N-(2-(1H-benzo[d]imidazol-2-yl)phenyl)cinnamides as tubulin polymerization inhibitors. Donthiboina K, Anchi P, Gurram S, Sai Mani G, Lakshmi Uppu J, Godugu C, Shankaraiah N, Kamal A. Bioorg Chem; 2020 Oct 15; 103():104191. PubMed ID: 32891862 [Abstract] [Full Text] [Related] Page: [Next] [New Search]